Retinitis Pigmentosa
Bionic eye maker has vision of the future
Robert Greenberg got tired of hearing from senior engineers that it wasn't possible to build his product idea: a bionic eye that gives sight to the blind. "A lot of the folks straight out of school didn't know any better, ...
Medical research
May 06, 2013 |
5 / 5 (6) |
1
Eye implants make vision-restoring progress
(Medical Xpress) -- "I was blind once but now I can see.” The words are no longer the sole property of religious testimony and literature. Medical progress is being made in the restoration of vision as ...
Ophthalmology
Jul 18, 2012 |
4.6 / 5 (10) |
4
|
New stem cell approach for blindness successful in mice (w/ video)
(Medical Xpress)—Blind mice can see again, after Oxford University researchers transplanted developing cells into their eyes and found they could re-form the entire light-sensitive layer of the retina.
Ophthalmology
Jan 08, 2013 |
5 / 5 (10) |
0
|
Bionic eye gives hope to the blind
After years of research, the first bionic eye has seen the light of day in the United States, giving hope to the blind around the world.
Ophthalmology
Feb 05, 2013 |
4.5 / 5 (11) |
0
Australians implant 'world first' bionic eye
Australian scientists said Thursday they had successfully implanted a "world first" bionic eye prototype, describing it as a major breakthrough for the visually impaired.
Ophthalmology
Aug 30, 2012 |
5 / 5 (9) |
0
Engineer invents bionic eye to help the blind
(Medical Xpress)—For UCLA bioengineering professor Wentai Liu, more than two decades of visionary research burst into the headlines last month when the FDA approved what it called "the first bionic eye for the blind." ...
Ophthalmology
Mar 25, 2013 |
5 / 5 (4) |
0
|
Gene therapy research cures retinitis pigmentosa in dogs
Members of a University of Pennsylvania research team have shown that they can prevent, or even reverse, a blinding retinal disease, X-linked Retinitis Pigmentosa, or XLRP, in dogs.
Genetics
Jan 23, 2012 |
4.9 / 5 (15) |
0
|
Gene therapy restores sense of smell, may aid research into other diseases caused by cilia defects
Scientists have restored the sense of smell in mice through gene therapy for the first time—a hopeful sign for people who can't smell anything from birth or lose it due to disease.
Medical research
Sep 02, 2012 |
5 / 5 (3) |
1
|
Reseachers develop holographic technique for bionic vision
Researchers led by biomedical engineering Professor Shy Shoham of the Technion-Israel Institute of Technology are testing the power of holography to artificially stimulate cells in the eye, with hopes of ...
Medical research
Feb 26, 2013 |
5 / 5 (3) |
0
|
Scientists produce eye structures from human blood-derived stem cells
(Medical Xpress) -- For the first time, scientists at the University of Wisconsin-Madison have made early retina structures containing proliferating neuroretinal progenitor cells using induced pluripotent ...
Ophthalmology
Mar 14, 2012 |
5 / 5 (4) |
0
|
Artificial retina receives FDA approval
The U.S. Food and Drug Administration (FDA) granted market approval to an artificial retina technology today, the first bionic eye to be approved for patients in the United States. The prosthetic technology ...
Ophthalmology
Feb 14, 2013 |
5 / 5 (9) |
0
|
Altering eye cells may one day restore vision
(Medical Xpress)—Doctors may one day treat some forms of blindness by altering the genetic program of the light-sensing cells of the eye, according to scientists at Washington University School of Medicine ...
Ophthalmology
Jan 25, 2013 |
5 / 5 (3) |
0
|
Researchers develop gene therapy that could correct a common form of blindness
A new gene therapy method developed by University of Florida researchers has the potential to treat a common form of blindness that strikes both youngsters and adults. The technique works by replacing a malfunctioning gene ...
Ophthalmology
Jan 23, 2012 |
5 / 5 (2) |
0
|
Photoreceptor transplant restores vision in mice
Scientists funded by the Medical Research Council (MRC) have shown for the first time that transplanting light-sensitive photoreceptors into the eyes of visually impaired mice can restore their vision.
Medical research
Apr 18, 2012 |
5 / 5 (4) |
0
|
Stem cells improve visual function in blind mice
An experimental treatment for blindness, developed from a patient's skin cells, improved the vision of blind mice in a study conducted by Columbia ophthalmologists and stem cell researchers.
Medical research
Oct 01, 2012 |
5 / 5 (3) |
1
|
Retinitis pigmentosa (RP) is a group of genetic eye conditions that leads to incurable blindness. In the progression of symptoms for RP, night blindness generally precedes tunnel vision by years or even decades. Many people with RP do not become legally blind until their 40s or 50s and retain some sight all their lives. Others go completely blind from RP, in some cases as early as childhood. Progression of RP is different in each case.
RP is a type of progressive retinal dystrophy, a group of inherited disorders in which abnormalities of the photoreceptors (rods and cones) or the retinal pigment epithelium (RPE) of the retina lead to progressive visual loss. Affected individuals first experience defective dark adaptation or nyctalopia (night blindness), followed by reduction of the peripheral visual field (known as tunnel vision) and, sometimes, loss of central vision late in the course of the disease.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
Latest Spotlight News
Genetic predictors of postpartum depression uncovered
Johns Hopkins researchers say they have discovered specific chemical alterations in two genes that, when present during pregnancy, reliably predict whether a woman will develop postpartum depression.
New immune system discovered
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.
The compound in the Mediterranean diet that makes cancer cells 'mortal'
New research suggests that a compound abundant in the Mediterranean diet takes away cancer cells' "superpower" to escape death. By altering a very specific step in gene regulation, this compound essentially re-educates cancer ...
Early-life traffic-related air pollution exposure linked to hyperactivity
Early-life exposure to traffic-related air pollution was significantly associated with higher hyperactivity scores at age 7, according to new research from the University of Cincinnati (UC) and Cincinnati Children's Hospital ...
Do salamanders hold the solution to regeneration?
Salamanders' immune systems are key to their remarkable ability to regrow limbs, and could also underpin their ability to regenerate spinal cords, brain tissue and even parts of their hearts, scientists have ...
Scientists identify molecular trigger for Alzheimer's disease
Researchers have pinpointed a catalytic trigger for the onset of Alzheimer's disease – when the fundamental structure of a protein molecule changes to cause a chain reaction that leads to the death of neurons ...
Practice makes perfect? Not so much
Turns out, that old "practice makes perfect" adage may be overblown. New research led by Michigan State University's Zach Hambrick finds that a copious amount of practice is not enough to explain why people ...
Neurons that can multitask greatly enhance the brain's computational power, study finds
Over the past few decades, neuroscientists have made much progress in mapping the brain by deciphering the functions of individual neurons that perform very specific tasks, such as recognizing the location ...
Immune protein could stop diabetes in its tracks
Melbourne researchers have identified an immune protein that has the potential to stop or reverse the development of type 1 diabetes in its early stages, before insulin-producing cells have been destroyed.
Older prostate cancer patients should think twice before undergoing treatment
Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA ...
